-
May 21, 2013
Elan seems to be set on wasting the Tysabri windfall instead of returning it to shareholders
-
May 09, 2013
More questions about the real efficacy of fish oil is bad news for Amarin.
-
February 13, 2013
Theravance Inc.'s (THRX) fourth quarter 2012 loss of 33 cents per share was narrower than the Zacks Consensus loss ...
-
February 12, 2013
Global biotechnology tools company - Life Technologies Corporation (LIFE) recently received 510(k) clearance from ...
-
February 07, 2013
GlaxoSmithKline (GSK) reported fourth quarter earnings of 57 cents per ADS, missing the Zacks Consensus Estimate of ...
-
February 06, 2013
GlaxoSmithKline (GSK) recently increased its holding in its consumer healthcare subsidiary in India, GlaxoSmithKline ...
-
February 04, 2013
Recently, GlaxoSmithKline (GSK) announced the initiation of a phase III study (COMBI-AD) to evaluate its oncology ...
-
January 31, 2013
Auxilium Pharmaceuticals, Inc. (AUXL) recently announced the initiation of a patent infringement lawsuit against ...
-
January 29, 2013
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the ...
-
January 29, 2013
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the ...
-
January 29, 2013
We expect Perrigo Company (PRGO) to beat expectations when it releases its second quarter fiscal 2013 results ...
-
January 28, 2013
Dr. Reddy's Laboratories (RDY) recently announced the launch of its generic version of Merck & Co's (MRK) Singulair ...
-
January 28, 2013
Theravance, Inc. (THRX) recently announced that it has completed its public offering of $287.5 million convertible ...
-
January 24, 2013
Perrigo Company (PRGO) recently announced that it has launched over-the-counter (OTC) nicotine polacrilex mini ...
-
January 23, 2013
Impax Laboratories, Inc. (IPXL) received a major setback recently with the US Food and Drug Administration (FDA) ...
-
January 18, 2013
NuPathe, Inc. (PATH) announced that the US Food and Drug Administration (FDA) has approved Zecuity (sumatriptan ...
-
January 17, 2013
Theravance, Inc. (THRX) announced recently that it intends to offer $250 million convertible subordinated notes, due ...
-
January 16, 2013
Perrigo Company (PRGO) recently announced that it has launched betamethasone valerate foam 0.12%. It is the generic ...
-
January 15, 2013
GlaxoSmithKline (GSK) recently announced the submission of a marketing application to the US Food and Drug ...
-
January 11, 2013
Isis Pharmaceuticals, Inc. (ISIS) recently provided an update on its pipeline. Isis Pharma boasts of a robust ...
